XBOT — Realbotix Income Statement
0.000.00%
- CA$50.35m
- CA$51.93m
- $1.28m
Annual income statement for Realbotix, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 9 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 1.08 | 0.678 | 0.74 | 1.28 |
Cost of Revenue | |||||
Gross Profit | — | 1.05 | 0.651 | 0.535 | 0.551 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -2.16 | 6.34 | 6.46 | 11.7 | 12.6 |
Operating Profit | 2.16 | -5.26 | -5.78 | -11 | -11.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.17 | -9.2 | -5.73 | -10.1 | -8.54 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.17 | -8.28 | -5.91 | -10.1 | -8.14 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.17 | -8.26 | -3.82 | -9.73 | -8.68 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.17 | -8.26 | -3.82 | -9.73 | -8.68 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.148 | -0.106 | -0.014 | -0.019 | -0.019 |
Dividends per Share |